Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model

ASIA unversity > 醫學暨健康學院 > 生物科技學系 > 期刊論文 > Item 310904400/8255

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/8255

题名:	Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model
作者:	Ho, YT (Ho, Yung-Tsuan);Yang, JS (Yang, Jai-Sing);Lu, CC (Lu, Chi-Cheng);Chiang, JH (Chiang, Jo-Hua);Li, TC (Li, Tsai-Chung);Lin, JJ (Lin, Jen-Jyh);Lai, KC (Lai, Kuang-Chi);Liao, CL (Liao, Ching-Lung);Lin, JG (Lin, Jaung-Geng);Chung, JG (Chung, Jing-Gung)
贡献者:	Department of Biotechnology
关键词:	Berberine;Human tongue SCC-4 cancer cells;Xenograft transplantation;In vivo
日期:	2009-09
上传时间:	2010-03-26 10:29:22 (UTC+8)
出版者:	Asia University
摘要:	Our primary studies showed that berberine induced apoptosis in human tongue cancer SCC-4 cells in vitro. But there is no report to show berberine inhibited SCC-4 cancer cells in vivo on a murine xenograft animal model. SCC-4 tumor cells were implanted into mice and groups of mice were treated with vehicle, berberine (10 mg/kg of body weight) and doxorubicin (4 mg/kg of body weight). The tested agents were injected once per four days intraperitoneally (i.p.), with treatment starting 4 weeks prior to cells inoculation. Treatment with 4 mg/kg of doxorubicin or with 10 mg/kg of berberine resulted in a reduction in tumor incidence. Tumor size in xenograft mice treated with 10 mg/kg berberine was significantly smaller than that in the control group. Our findings indicated that berbeirne inhibits tumor growth in a xenograft animal model. Therefore, berberine may represent a tongue cancer preventive agent and can be used in clinic. (c) 2009 Elsevier GmbH. All rights reserved.
關聯:	PHYTOMEDICINE 16 (9): 887-890
显示于类别:	[生物科技學系] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html		0Kb	HTML	506	检视/开启
150.doc		37Kb	Microsoft Word	319	检视/开启

在ASIAIR中所有的数据项都受到原著作权保护.

数据加载中.....